Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Indonesia Prima Property Tbk: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Indonesia Prima Property Tbk diperdagangkan di Rp1.160 (kapitalisasi pasar 3,84 T, volume 24 jam 275 rb). Perbedaan utamanya: Indonesia Prima Property Tbk jauh lebih besar — sekitar 22,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (592,2 rb vs 275 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | OMRE | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 3,84 T |
Volume | 592,2 rb | 275 rb |
Lot | 5,92 rb | 2,75 rb |
Perputaran | 147,05 jt | 321,21 jt |
Harga Rata-rata | 248,31 | 1.168,03 |
Nilai Transaksi | 147,05 jt | 321,21 jt |
Harga Ekuilibrium Indikatif | 254 | 1.160 |
Volume Ekuilibrium Indikatif | 10 | 62 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Indonesia Prima Property Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on notarial deed No. 31 dated April 23, 1983 of Sastra Kosasih, S.H., notary in Surabaya. PT Ometraco Realty, is a member of the Ometraco Group. The company operates in developing and managing apartments, office properties, hotels and shopping centers.
Selengkapnya di halaman OMRE →